Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1989 1
1995 1
1998 1
2000 1
2005 1
2006 1
2008 3
2010 2
2011 4
2012 23
2013 24
2014 23
2015 13
2016 3
2017 1
2018 7
2019 8
2020 16
2021 12
2022 13
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision.
Asher WB, Terry DS, Gregorio GGA, Kahsai AW, Borgia A, Xie B, Modak A, Zhu Y, Jang W, Govindaraju A, Huang LY, Inoue A, Lambert NA, Gurevich VV, Shi L, Lefkowitz RJ, Blanchard SC, Javitch JA. Asher WB, et al. Among authors: borgia a. Cell. 2022 May 12;185(10):1661-1675.e16. doi: 10.1016/j.cell.2022.03.042. Epub 2022 Apr 27. Cell. 2022. PMID: 35483373 Free PMC article.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside.
Allegrini D, Raimondi R, Borgia A, Sorrentino T, Montesano G, Tsoutsanis P, Cancian G, Verma Y, De Rosa FP, Romano MR. Allegrini D, et al. Among authors: borgia a. Int J Mol Sci. 2022 Mar 24;23(7):3557. doi: 10.3390/ijms23073557. Int J Mol Sci. 2022. PMID: 35408920 Free PMC article. Review.
Resveratrol and cancer treatment: is hormesis a yet unsolved matter?
Borriello A, Bencivenga D, Caldarelli I, Tramontano A, Borgia A, Pirozzi AV, Oliva A, Della Ragione F. Borriello A, et al. Among authors: borgia a. Curr Pharm Des. 2013;19(30):5384-93. doi: 10.2174/1381612811319300007. Curr Pharm Des. 2013. PMID: 23394084 Review.
Optic disc drusen: a systematic review : Up-to-date and future perspective.
Allegrini D, Pagano L, Ferrara M, Borgia A, Sorrentino T, Montesano G, Angi M, Romano MR. Allegrini D, et al. Among authors: borgia a. Int Ophthalmol. 2020 Aug;40(8):2119-2127. doi: 10.1007/s10792-020-01365-w. Epub 2020 May 7. Int Ophthalmol. 2020. PMID: 32383130 Review.
167 results